The lawsuit in Connecticut federal court accused Aetna of violating the Employee Retirement Income Security Act by denying claims for transcranial magnetic stimulation, a treatment for major depression. The $6.2 million settlement, which U.S. District Judge Janet C. Hall approved Feb. 15, would end the litigation.
Once attorneys’ fees and other costs are deducted, patients and families who paid out of pocket for the treatment may be able to collect about 70 percent of what they would have received if their claims were reprocessed, according to Law360. All class members are expected to receive at least $1,500 under the agreement.
More articles on payers:
BCBS Association CEO to testify in court over Anthem-Cigna breakup
The state of Medicaid expansion
After reviewing 173 comments, DOJ stands by CVS-Aetna settlement
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
